CURRICULUM VITAE Last update May 3, 2020 PERSONAL INFORMATION NAME KHALIL GHASEMI FALAVARJANI ADDRESS Eye Department, Rassoul Akram Hospital, Sattarkhan-Niayesh St. POBox:1445613131 Tehran, Iran Phone: +98 21 66509162 Fax: +98 21 66509162 Email: drghasemi@yahoo.com NATIONALITY Iranian LANGUAGE Farsi, English EDUCATIONS International Retina Fellowship Doheny/Stein Eye Institute - UCLA, LA, USA 2015-16 Surgical and Medical retina Iran University of Medical Sciences (IUMS) Fellowship Tehran, Iran 2008-09 Ophthalmic Oncology IUMS, Tehran, Iran 2009-10 Iranian Board Certification IUMS 2007 in Ophthalmology and Tehran, Iran Ophthalmic Surgery with "A" score. Ophthalmology Residency Rassoul Akram General Hospital 2003-2007 IUMS, Tehran, Iran POSITIONS Editor In Chief Journal of Current Ophthalmology (Iranian Journal of Ophthalmology) 2015-Cont’ Chair Eye Department, IUMS 2019-Cont’ Director Eye Department, Rassoul Hospital, IUMS 2011- 19

Dean CME office, IUMS 2010 Member Iranian National Board of Ophthalmology 2015-19 Member Iran National Ophthalmology Review Board 2015-19 Member Iranian Vitreoretina Society Board of Directors 2018-20 Member Iran Supreme Medical Council 2014-2015 (Ophthalmology committee) Editorial Board Middle East African Journal of Ophthalmology (MEAJO) 2012-18 Editorial Board, Section Editor Journal of Ophthalmology and Vision Research 2009-cont’ Member Iran Research Association for Vision & Ophthalmology (IRAVO) Board of Directors 2018-Cont’ Editorial Board Iranian Journal of Ophthalmology 2009-2015 Editorial Board Journal of Laser in Medicine 2009-2011 Member IUMS Eye Research Center Supreme Council 2015-17 Scientific Director Second Spring Ophthalmology Meeting 2018 Scientific Board Annual Meeting of Iranian Society of Ophthalmology 2010-cont’ Scientific Board First Iranian Vision Research Seminar 2010 Scientific Board 19th Farabi Annual Meeting 2013 Scientific Board Annual Meeting, Eye Research Center, IUMS 2007-cont’ International Committee Iranian Society of Ophthalmology 2009-cont’ Director 4th Annual Ophthalmology Congress, Eye Department, IUMS 2010 Scientific Reviewer Ophthalmology Retina 2016- cont’ Scientific Reviewer Ophthalmology 2016- cont’ Scientific Reviewer MEAJO 2013-cont’

Scientific Reviewer International Journal of Ophthalmology 2013-cont’ Expert Board International Journal of Ophthalmology 2014 Scientific Reviewer Current Eye Research 2016 Scientific Reviewer Graefes Archives of Clinical and Experimental Ophthalmology 2016-18 Scientific Reviewer Eye 2016 Scientific Reviewer Ophthalmologica 2016-17 Scientific Reviewer Cutaneous and Ocular Toxicicology 2015-16 Scientific Reviewer American Journal of Ophthalmology 2011-Cont’ Scientific Reviewer European Journal of Ophthalmology 2019 Scientific Reviewer Journal of Research in Medical Sciences 2012 Scientific Reviewer Journal of Ophthalmology and Vision Research 2009-cont’ Scientific Reviewer Journal of Cataract and Refractive Surgery 2008-2017 Scientific Reviewer Journal of Current Diabetes Research 2013 Scientific Reviewer Ophthalmic Plastic and Reconstructive Surgery 2014 Scientific Reviewer Saudi Journal of Ophthalmology 2014-cont’ Scientific Reviewer Journal of Expert Opinion on Drug Delivery 2014 Scientific Reviewer Journal of Acta Ophthalmology 2010-2019 Scientific Reviewer Indian Journal of Ophthalmology 2008-cont’ Scientific Reviewer Iranian Journal of Ophthalmology 2008-2015 Scientific Editor Cheshmkhaneh periodical eye journal 2007-2014 Ophthalmic Paraclinic Director Rassoul Akram University hospital 2007-2011 Tehran, Iran Assistant Director of Research Eye Research Center, IUMS 2007-2009

HONORS and AWARDS

Educational Award of the Iran University of Medical Sciences (Vosough Festival) 2020 Distinct Researcher, Iran University of Medical Sciences 2020 Distinct Researcher, Iran University of Medical Sciences 2018 Outstanding reviewer, American Journal of Ophthalmology 2018 Outstanding reviewer, Ophthalmology (American Academy) 2017 Distinct Researcher, Rassoul Akram Hospital 2016 Best Review article, Shams Ophthalmology Award 2016 Distinct Young Researcher, Avicenna Medical Festival 2013 Tehran University of Medical Sciences (TUMS) Distinct Researcher, Razi International Medical Festival 2012 Iran Health Ministry, Tehran. Ophthalmology Scholar Award, Shams Festival of Ophthalmology and Visual Science, Tehran, Iran 2011 Sicca Research Award, Iranian Society of Ophthalmology 2010 Best Researcher, IUMS 2009 Ranked 2nd in Iranian Ophthalmology Board examination 2007 Best Resident, IUMS 2007 Ranked 2nd in pre-internship general examination 1997 Ranked 3rd in medical basic science general examination 1994

WORKING EXPERIENCES IUMS Associate Professor of Ophthalmology, 2014-cont’

Retina division, Rassoul Akram Hospital, Tehran, Iran IUMS Assistant Professor of Ophthalmology, 2009-2014 Retina division, Rassoul Akram Hospital, Tehran, Iran TUMS Assistant Professor of Ophthalmology, 2013 Retina division, Farabi Eye Hospital, Tehran, Iran IUMS Assistant professor of ophthalmology, 2011-2012 Ophthalmic Oncology Unit, Rassoul Akram Hospital, Tehran, Iran IUMS Assistant professor of ophthalmology, 2007-2008 General Ophthalmology, Rassoul Akram Hospital, Tehran, Iran Governmental Health Center, Isfahan, General Practitioner 2001-2003 Iran Iran Health Ministry, Tehran, Iran General Practitioner (conscription) 1999-2001 RESEARCHES AND PUBLICATIONS A. English publications 1. Falavarjani KG, Hadavandkhani A, Parvaresh MM, et al. Intra-silicone Oil Injection

of Methotrexate in Retinal Reattachment Surgery for Proliferative Vitreoretinopathy. Ocul Immunol Inflamm. 2020 Apr 2;28(3):513-516. [Medline]

2. Naseripour M, Falavarjani KG, Sedaghat A, Mirshahi R. Optical coherence tomography angiography (OCTA) applications in ocular oncology. Eye. 2020 Mar 03. [Medline]

3. Darvizeh F, Asanad S, Falavarjani KG, et al. Choroidal thickness and the retinal ganglion cell complex in chronic Leber's hereditary optic neuropathy: a prospective study using swept-source optical coherence tomography. Eye (Lond). 2019 Dec 5. [Medline]

4. Falavarjani KG, Au A, Anvari P, Molaei S, et al. En Face OCT of Type 2 Neovascularization:A Reappraisal of the Pitchfork Sign. Ophthalmic Surg Lasers Imaging Retina. 2019 Nov 1;50(11):719-725. [Medline]

5. Fan W, Nittala MG, Fleming A, et al. Relationship Between Retinal Fractal

Dimension and Non-perfusion in Diabetic Retinopathy on Ultra-Wide Field Fluorescein Angiography. Am J Ophthalmol. 2020; 209, 99-106. [Medline]

6. Abri Aghdam K, Ashraf Khorasani M, Soltan Sanjari M, et al. Optical coherence tomography angiography features of optic nerve head drusen and nonarteritic anterior ischemic optic neuropathy. Can J Ophthalmol. 2019;54(4):495-500. [Medline]

7. Falavarjani KG, Anvari P. Surgical Removal of Submacular Perfluorocarbon Liquid Using a 41-Gauge Extendible Subretinal Injection Needle. J Ophthalmic Vis Res. 2019;14(3):393-397. [Medline]

8. Fan W, Uji A, Wang K, Falavarjani KG, et al. SEVERITY OF DIABETIC MACULAR EDEMA CORRELATES WITH RETINAL VASCULAR BED AREA ON ULTRA-WIDE FIELD FLUORESCEIN ANGIOGRAPHY: DAVE Study. Retina. 2019 Jul 26. [Medline]

9. Falavarjani KG, Habibi A, Anvari P, et al. Effect of segmentation error correction on

optical coherence tomography angiography measurements in healthy subjects and diabetic macular oedema. Br J Ophthalmol. 2019 Apr 29. [Medline]

10. Asanad S, Tian JJ, Frousiakis S, et al. Optical Coherence Tomography of the Retinal

Ganglion Cell Complex in Leber's Hereditary Optic Neuropathy and Dominant Optic Atrophy. Curr Eye Res. 2019 Jan 16. [Medline]

11. Fang M, Fan W, Shi Y, Ip MS, Wykoff CC, Wang K, Falavarjani KG, et al. Classification of Regions of Nonperfusion on Ultra-widefield Fluorescein Angiography in patients with Diabetic Macular Edema. Am J Ophthalmol. 2019 Apr 5. [Medline]

12. Falavarjani KG, Hadi Y, Habibi A, et al. Efficacy of topical timolol eye drops for the treatment of diabetic macular edema. Ophthalmology Retina. 2019 Jun;3(6):538-539. [Medline]

13. Khadamy J, Abri Aghdam K, Falavarjani KG. An Update on Optical Coherence Tomography Angiography in Diabetic Retinopathy. J Ophthalmic Vis Res. 2018; 13(4):487-497. [Medline]

14. Leng Y, Tam EK, Falavarjani KG, Tsui I. Effect of Age and Myopia on Retinal Microvasculature. Ophthalmic Surg Lasers Imaging Retina. 2018;49(12):925-931. [Medline]

15. Ghasemi Falavarjani K. My Approach to Retinal Detachment: An Iranian Surgeon’s Perspective. In: Spandau U, Tomic Z, Ruiz-Cascas D. Retinal Detachment Surgery

and Proliferative Vitreoretinopathy. 2018. Springer. Switzerland. (Book Chapter)

16. Anvari P, Ghasemi Falavarjani K. Adjunctive Pharmacological Therapies in the Management of Proliferative Vitreoretinopathy. In: Spandau U, Tomic Z, Ruiz-Cascas D. Retinal Detachment Surgery and Proliferative Vitreoretinopathy. 2018. Springer. Switzerland. (Book Chapter)

17. GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1923-1994. [Medline]

18. GBD 2017 Population and Fertility Collaborators. Population and fertility by age and sex for 195 countries and territories, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1995-2051. [Medline]

19. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 ;392(10159):1789-1858. [Medline]

20. GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):1736-1788. [Medline]

21. GBD 2017 Mortality Collaborators. Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):1684-1735. [Medline]

22. GBD 2016 Healthcare Access and Quality Collaborators. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. Lancet. 2018 Jun 2;391(10136):2236-2271. [Medline]

23. Falavarjani KG, Shenazandi H, Naseri D, et al. Foveal Avascular Zone and Vessel Density in Healthy Subjects: An Optical Coherence Tomography Angiography Study. J Ophthalmic Vis Res. 2018; 13(3):260-265. [Medline]

24. Falavarjani KG, Shenazandi H, Naseri D, et al. Correlation of optic disc morphometry and optic disc microvasculature assessed with optical coherence tomography angiography. Can J Ophthalmol 2018. 2018;53(6):595-599. [Medline]

25. Wang K, Ghasemi Falavarjani K, Nittala MG, et al. Ultra-Wide-Field Fluorescein

Angiography-Guided Normalization of Ischemic Index Calculation in Eyes With Retinal Vein Occlusion. Invest Ophthalmol Vis Sci. 2018;59(8):3278-3285. [Medline]

26. Fujinami K, Strauss RW, Chiang JP, et al. Detailed genetic characteristics of an international large cohort of patients with Stargardt disease: ProgStar study report 8. Br J Ophthalmol. 2018 Jun 20. [Medline]

27. Kong X, Fujinami K, Strauss RW, et al. Visual Acuity Change Over 24 Months and its Association With Foveal Phenotype and Genotype in Individuals With Stargardt Disease: ProgStar Study Report No. 10. JAMA ophthalmology 2018. [Medline]

28. GBD 2016 Healthcare Access and Quality Collaborators. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. Lancet. 2018;391(10136):2236-2271. [Medline]

29. Nikkhah H, Karimi S, Ahmadieh H, et al. Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents for Ocular Vascular Diseases: Clinical Practice Guideline. J Ophthalmic Vis Res. 2018;13(2):158-169. [Medline]

30. Falavarjani KG, Habibi A, Khorasani MA, Anvari P, Sadda SR. Time course of changes in optic disk neovascularization after a single intravitreal bevacizumab injection. Retina. 2018 Feb 19. [Medline]

31. Falavarjani KG, Sarraf D, Tsui I. Optical Coherence Tomography Angiography of the Macula in Adults With a History of Preterm Birth. Ophthalmic Surg Lasers Imaging Retina. 2018;49(2):122-125. [Medline]

32. Mittal A, Velaga SB, Falavarjani KG, et al. Choroidal thickness in non-ocular Behçet's disease - A spectral-domain OCT study. J Curr Ophthalmol. 2017 Jun 26;29(3):210-213. [Medline]

33. Al-Sheikh M, Falavarjani KG, Pfau M, et al. Quantitative Features of the Choriocapillaris in Healthy Individuals Using Swept-Source Optical Coherence Tomography Angiography. Ophthalmic Surg Lasers Imaging Retina. 2017 Aug 1;48(8):623-631. [Medline]

34. Akil H, Al-Sheikh M, Falavarjani KG, et al. Swept-source OCT angiography imaging of the macular capillary network in glaucoma. Br J Ophthalmol. 2017 Aug 9. [Medline]

35. Ghasemi Falavarjani K, Amirsardari A, Habibi A, et al. Visual and Anatomical Outcomes of Spironolactone Therapy in Patients with Chronic Central Serous Chorioretinopathy. J Ophthalmic Vis Res. 2017;12(3):281-289. [Medline]

36. Ghasemi K, Shaheen Y, Karimi MA, et al. Schirmer test changes after 20 gauge and 23 gauge pars plana vitrectomy. Rom J Ophthalmol. 2017 Jan-Mar;61(1):39-43. [Medline]

37. Ghasemi Falavarjani K, Alemzadeh SA, Modarres M, et al. Outcome of surgery in patients with giant retinal tear: 10 years experience. Eye (Lond). 2017 Aug 4. [Medline]

38. Ghasemi Falavarjani K, Tsui I, Sadda SR. Ultra-wide-field imaging in diabetic retinopathy. Vision Res. 2017 Jul 5. [Medline]

39. Strauss RW, Muñoz B, Ho A, et al. Incidence of Atrophic Lesions in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 5. JAMA Ophthalmol. 2017;135(7):687-695. [Medline]

40. Strauss RW, Muñoz B, Ho A, et al. Progression of Stargardt Disease as Determined by Fundus Autofluorescence in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 9). JAMA Ophthalmol. 2017;135(11):1232-1241. [Medline]

41. Schönbach EM, Wolfson Y, Strauss RW, et al. Macular Sensitivity Measured With Microperimetry in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 7. JAMA Ophthalmol. 2017;135(7):696-703. [Medline]

42. Fan W, Wang K, Ghasemi Falavarjani K, et al. Distribution of Nonperfusion Area on Ultra-Wide Field Fluorescein Angiography in Eyes with Diabetic Macular Edema: DAVE Study. Am J Ophthalmol. 2017;180:110-116. [Medline]

43. Al-Sheikh M, Falavarjani KG, Akil H, Sadda SR. Impact of image quality on OCT angiography based quantitative measurements. Int J Retina Vitreous. 2017 May 15;3:13. [Medline]

44. Al-Sheikh M, Falavarjani KG, Tepelus TC, Sadda SR. Quantitative Comparison of Swept-Source and Spectral-Domain OCT Angiography in Healthy Eyes. Ophthalmic Surg Lasers Imaging Retina. 2017;48(5):385-391. [Medline]

45. Falavarjani KG, Sarraf D. Optical coherence tomography angiography of the retina and choroid; current applications and future directions. J Curr Ophthalmol 2017;29:1-4. [Medline]

46. Falavarjani KG, Phasukkijwatana N, Freund KB, et al. En Face OCT Analysis to Assess the Spectrum of Perivenular Ischemia and Paracentral Acute Middle Maculopathy in Retinal Vein Occlusion. Am J Ophthalmol. 2017;177:131-138. [Medline]

47. Hedayatfar A, Hosseini SM, Karimi N, Falavarjani KG, et al. The spectrum of Vogt-

Koyanagi-Harada disease in Iran. Int Ophthalmol. 2017 Mar 4. [Medline]

48. Akil H, Falavarjani KG, Sadda SR, Sadun AA. Optical Coherence Tomography Angiography of the Optic Disc; an Overview. J Ophthalmic Vis Res. 2017;12(1):98-105. [Medline]

49. Akil H, Al-Sheikh M, Falavarjani KG, et al. Choroidal thickness and structural glaucoma parameters in glaucomatous, preperimetric glaucomatous, and healthy eyes using swept-source OCT. Eur J Ophthalmol. 2017 Aug 30;27(5):548-554. [Medline]

50. Falavarjani KG, Iafe NA, Velez FG, et al. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF THE FOVEA IN CHILDREN BORN PRETERM. Retina (in press) [Medline]

51. Falavarjani KG, Iafe NA, Hubschman JP, et al. Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein OcclusionOCTA After Intravitreal Injection. Investigative Ophthalmology & Visual Science 2017; 58 (1), 30-34. [Medline]

52. Falavarjani KG, Aghamirsalim M, Aghdam KA. Resident-performed neodymium: YAG laser posterior capsulotomy. Can J Ophthalmol 2017;52(4):324-330. [Medline]

53. Garcia GA, Tian JJ, Falavarjani KG, et al. Corneal etching in femtosecond laser-assisted cataract surgery. Can J Ophthalmol 2017 Feb;52(1):e15-e18. [Medline]

54. Falavarjani KG, Sadda SR. Hot topic in pharmacotherapy for neovascular age-related macular degeneration. Curr Pharm Des. 2017;23(4):535-541. [Medline]

55. Falavarjani KG, Al-sheikh M, Darvizeh F, et al. Retinal vessel calibre measurements by optical coherence tomography angiography. Br J Ophthalmol. 2016 2017 Jul;101(7):989-992. [Medline]

56. Falavarjani KG, Habibi A, Pourhabibi A, et al. Retinal toxicity of intravitreal granulocyte colony-stimulating factor in rabbit eyes. Curr Eye Res 2017;42(4):636-639. [Medline]

57. Rajavi Z, Safi S, Javadi MA, Falavarjani KG, et al. Diabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population. J Ophthalmic Vis Res. 2016;11(4):394-414. [Medline]

58. Abri Aghdam K, Khadamy J, Falavarjani KG, Tsui I. Refractive outcomes following

the treatment of retinopathy of prematurity in the anti-VEGF era: a literature review. J AAPOS. 2016;20(6):539-540.

59. Aghai G, Diabjnia P, Ashkesh E, Nazari M, Falavarjani KG. Behavior disorders in children with significant refractive errors. J Curr Ophthalmol 2016;28(4):223-225.

60. Falavarjani KG, Tian JJ, Akil H, Garcia GA, Sadda SR, Sadun AA. Swept-source optical coherence tomography angiography of the optic disc in optic neuropathy. Retina 2016 Dec;36 Suppl 1:S168-S177. [Medline]

61. Falavarjani KG, Wang K, Khadamy J, Sadda SR. Ultra-wide-field imaging in diabetic retinopathy; an overview. J Curr Ophthalmol 2016;28(2):57-60. [Medline]

62. Falavarjani KG, Scott AW, Wang K, et al. Correlation of Multimodal Imaging in Sickle Cell Retinopathy. Retina Dec;36 Suppl 1:S111-S117. [Medline]

63. Falavarjani KG, Al-Sheikh M, Akil H, Sadda SR. Image artefacts in swept-source optical coherence tomography angiography. Br J Ophthalmol. 2017;101(5):564-568. [Medline]

64. Falavarjani KG, Golabi S, Modarres M. Intravitreal injection of methotrexate in persistent diabetic macular edema: a 6-month follow-up study. Graefes Arch Clin Exp Ophthalmol 2016 Nov;254(11):2159-2164. [Medline]

65. Falavarjani KG, Mehrpouya A, Amirkourjani F. Effect of spectral domain optical coherence tomography image quality on macular thickness measurements and error rate. Curr Eye Res. 2017; 42(2):282-286. [Medline]

66. Hedaiatfar A, Falavarjani KG, Soheilian M, et al. Mycophenolate Mofetil for the Treatment of Multiple Sclerosis associated Uveitis. Ocul Immunol Inflamm. 2016 Jul 5:1-7.

67. Falavarjani KG, Kashkouli MB, Chams H. Letter to editor, a scientific forum for discussion. J Curr Ophthalmol 2016; 28:1-2. [Medline]

68. Aghdam KA, Sanjari MS, Falavarjani KG. Erythropoietin in ophthalmology: a

literature review. J Curr Ophthalmol 2016; 28:5-11. [Medline]

69. Falavarjani KG, Modarres M. Double pseudohypopyon from emulsified heavy silicone oil. Retinal cases and brief reports. 2017;11(2):126-127. [Medline]

70. Falavarjani KG, Alemzadeh SA, Habibi A, et al. Pseudomonas aeruginosa Endophthalmitis: Clinical Outcomes and Antibiotic Susceptibilities. Ocul Immunol Inflamm. 2016 Feb 24:1-5. [Medline]

71. Askari M, Nikpoor AR, Gorjipour F, Mazidi M, Sanati MH, Aryan H, Irani A,

Ghasemi Falavarjani K, et al. Association of Htra1 gene polymorphisms with the risk of developing AMD in Iranian population. Rep Biochem Mol Biol. 2015;4(1):43-9. [Medline]

72. Naseripour M, Jaberi R, Sedaghat A, Azma Z, Nojomi M, Falavarjani KG, Nazari H. Ruthenium-106 brachytherapy for thick uveal melanoma: reappraisal of apex and base dose radiation and dose rate. J Contemp Brachytherapy. 2016;8(1):66-73. [Medline]

73. Falavarjani KG, Golabi S, Hadavandkhani A. Effect of Intravitreal Injection of Methotrexate on Human Corneal Endothelial Cells. Cornea 2016;35(2):217-9. [Medline]

74. Aghai GH, Gordiz A, Falavarjani KG, Kashkouli M. Anterior lamellar recession, blepharoplasty, and supratarsal fixation for cicatricial upper eyelid entropion without lagophthalmos. Eye (Lond) 2016;30(4):627-31. [Medline]

75. Falavarjani KG, Khadamy J, Amirkourjani F, et al. Macular thickness measurement in clinically significant macular edema before and after meal. J Curr Ophthalmol 2015; 27:125-128. [Medline]

76. Falavarjani KG, Pourhabibi A, Abri Aghdam K, et al. Detemination of the toxicity of intravitreal minocycline. Cutaneous and Ocular Toxicicology 2016 35(3):233-6. [Medline]

77. Naseripour M, Falavarjani KG, Sedaghat A, et al. Half-Dose Photodynamic Therapy

for Chronic Central Serous Chorioretinopathy. JOVR 2016; 11 (1): 66-69. [Medline]

78. Naseripour M, Ghasempour A, Falavarjani KG, et al. Perfluorocarbon liquid migration into the subarachnoid space in a patient with morning glory syndrome. J Curr Ophthalmol 2015;27:60-2. [Medline]

79. Falavarjani KG, Khadamy J, Eshaghi A, et al. Pattern Dystrophy Associated with Bilateral Submacular Fluid; a Multimodal Imaging Study. J Clin Exp Ophthalmol 2015; 6 (505), 2

80. Yazdi MH, Faramarzi MA, Nikfar S, Falavarjani KG, Abdollahi M. Ranibizumab an

d aflibercept for the treatment of wet age-related macular degeneration. Expert Opin Biol Ther 2015; 15(9):1349-1358 [Medline]

81. Falavarjani KG, Modarres M, Hadavandkhani A, et al. Intrasilicone oil injection of

methotrexate at the end of vitrectomy for advanced proliferative diabetic retinopathy. Eye 2015;29(9):1199-203. [Medline]

82. Falavarjani KG, Khadamy J, Karimi N, et al. Posterior sub-tenon’s bevacizumab injection in diabetic macular edema; a pilot study. Saudi J Ophthalmology 2015;29:

270-273. [Medline]

83. Falavarjani KG, Khadamy J, Karimi N, et al. Optical Coherence Tomography Grid decentration and Its Effect on Macular Thickness Measurements. Iran J Ophthalmol 2014, 26(3):155-9. [Scopus]

84. Falavarjani KG, Alemzadeh SA, Modarres M, et al. Scleral Buckling Surgery for Rhegmatogenous Retinal Detachment with Subretinal Proliferation. Eye 2015: 29; 509–514. [Medline]

85. Falavarjani KG, Khadamy J, Safi H, et al. Effect of grid decentration on macular thickness measurements in normal subjects and patients with diabetic macular edema. Eur J Ophthalmol 2015;25(3):218-21. [Medline]

86. Hashemi S, Faramarzi MA, Ghasemi Falavarjani K, Abdollahi M. Bevacizumab for choroidal neovascularization secondary to age-related macular degeneration and pathological myopia. Expert Opin Biol Ther 2014;14(12):1837-48. [Medline]

87. Falavarjani KG, AghaMirsalim MR, Modarres M, et al. Endophthalmitis after resident-performed intravitreal bevacizumab injection. Can J Ophthalmol 2015;50:33-36. [Medline]

88. Falavarjani KG, Khoshamadi A, Nilforushan N. Peripapillary nerve fiber layer thickness changes after macular photocoagulation for clinically significant diabetic macular edema. Saudi J Ophthalmology 2015; 29: 67-70. [Pubmed]

89. Falavarjani KG, Modarres M. Proliferative vitreoretinopathy and antivascular endothelial growth factor treatment. Eye 2014;28(12):1525-6. [Medline]

90. Nazari Khanamiri H, Falavarjani KG, et al. Complement Factor H Y402H and LOC387715 A69S Polymorphisms in Association with Age-Related Macular Degeneration in Iran. JOVR 2014; 9 (2):181-187. [Pubmed]

91. Faghihi H, Ghassemi F, Falavarjani KG, et al. Spontaneous closure of traumatic macular holes. Canadian J Ophthalmology 2014;49(4):395-8. [Medline]

92. Falavarjani KG, Nguyen QD. Reply to Dr Grzybowski. Eye 2014;28(4):501. [Medline]

93. Falavarjani KG, Hashemi M, Modarres M, Khani AH. Intra-silicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy. Eye 2014;28(5):576-80. [Medline]

94. Modarres M, Rezanejad A, Falavarjani KG. Recurrence and massive extraocular extension of choroidal malignant melanoma after vitrectomy and endoresection. Indian J Ophthalmol 2014;62(6):731-3. [Medline]

95. Zhang Z, Liu H, Hernandez-Da mota SE, Romano MR, Falavarjani KG, Ahmadie H,

Xu X, Liu K. Vitrectomy with or without preoperative intravitreal bevacizumab for proliferative diabetic retinopathy: a meta analysis of randomized controlled trials. Am J Ophthalmol 2013;156:106-115. [Medline]

96. Eshraghi B, Masoomian B, Izadi A, Abedinifar Z, Falavarjani KG. Conjunctival bacterial flora and its changes after successful dacryocystorhinostomy. Ophthalmic Plastic Reconstruct surgery 2014; 30: 44-46. [Medline]

97. Hashemi M, Falavarjani KG, et al. Anterior segment study with the Pentacam Scheimpflug camera in refractive surgery candidates. Middle East Afr J Ophthalmol 2013;20:212-6. [Pubmed]

98. Falavarjani KG, Nguyen QD. Adverse events and complications associated with intravitreal injection of anti- VEGF agents; a review of literature. Eye (London). 2013;27:787-794. [Medline]

99. Falavarjani KG, Hashemi M, et al. Vitrectomy for posterior segment intraocular

foreign bodies, visual and anatomical outcomes. Middle East Afr J Ophthalmol 2013;20:244-247. [Pubmed]

100. Falavarjani KG. Proliferative Vitreoretinopathy and Genetic Profile. JOVR.

2013;8:92-3. [Pubmed]

101. Parvaresh MM, Falavarjani KG, et al. Transscleral diode laser retinal photocoagulation for the treatment of type one prethreshold retinopathy of prematurity in zone 2. JOVR. 2013; 8 (4): 298-302. [Pubmed]

102. Parvaresh MM, Falavarjani KG. Sympathetic ophthalmia after sclera buckling surgery. Retinal cases and brief reports 2013; 7(4):331-333. [Pubmed]

103. Aghai GH, Vazirnia M, Pourmatin R, Falavarjani KG. Effects of local anesthesia with bupivacaine plus epinephrine on blepharoptosis and levator palpebrae muscle function. Ophthalmic Plastic Reconstruct surgery. 2013;29:198-200. [Medline]

104. Josaghani M, Nazari H, Falavarjani KG, et al. Effect of Homatropine eye drops on pain after photorefractive keratectomy; a pilot study. Saudi J Ophalmol 2013; 27:83–85. [Scopus]

105. Fesharaki H, Kianersi F, Riazi H, Mehrnia A, Naderian G, Modarres M, Falavarjani KG. The effect of posterior versus anterior subtenon injection of triamcinolone on intraocular pressure in eyes with retinal vein occlusion. Iranian Journal of Ophthalmology 2012;24(4):25-30. [Scopus]

106. Falavarjani KG, Nekoozadeh S, Modarres M, et al. Isolates and Antibiotic

Resistance of Culture-Proven Endophthalmitis Cases Presented to a Referral Center in Tehran. Middle East Afr J Ophthalmol 2012;19:361-3. [Pubmed]

107. Hashemi M, Miraftabi A, Nilforushan N, Falavarjani KG, et al. Comparison of the Efficacy and Tolerability of Xalatan® and Xalabiost (Generic Latanoprost) in Adults with Open-Angle Glaucoma or Ocular Hypertension: A Two-Center, Randomized, Crossover Trial. Iranian Journal of Ophthalmology 2012;24(3):11-18. [Scopus]

108. Falavarjani KG, Parvaresh MM, Modarres M, et al. Intravitreal Bevacizumab for

Pseudophakic Cystoid Macular Edema; a Systematic Review. J Ophthalmic Vis Res 2012; 7(3): 235-239. [Pubmed]

109. Falavarjani KG, Modarres M, Hashemi M, et al. Incidence of acute endophthalmitis after intravitreal bevacizumab injection in a single clinical center. Retina 2013;33(5):971-4. [Medline]

110. Falavarjani KG, Parvaresh MM, Shahraki K, et al. Central retinal artery occlusion in Crohn disease. JAAPOS 2012; 16:392-3. [Medline]

111. Modarres M, Nazari H, Kanavi MR, Nikghbalil A, Falavarjani KG, Aghdam KA. Determination of Safety of Escalating Doses of Intravitreal Erythropoietin in Rabbit Eyes. Iranian Journal of Ophthalmology 2012;24(2):26-32. [Scopus]

112. Falavarjani KG, Hashemi M, Fazel AJ, et al. Pars Plana Vitrectomy and Intravitreal Phacoemulsification for Dropped Nuclei. J Ophthalmic Vis Res 2012; 7 (2): 125-129. [Pubmed]

113. Falavarjani KG, Sanjari MS. Detection of optic disc oedema using optical coherence tomography. Br J Ophthalmol 2012;96:1355-1357. [Medline]

114. Rohani M, Langroodi AS, Ghourchian S, Falavarjani KG, Soudi R, Shahidi G. Retinal nerve changes in patients with tremor dominant and akinetic rigid Parkinson's disease. Neurol Sci. 2013; 34:689-93. [Medline]

115. Soleimani M, Falavarjani KG, Foroutan AR. Pupil size and LASIK. Ophthalmology. 2012;119(4):882-3. [Medline]

116. Falavarjani KG, Modarres M. Heavy Silicone Oil Removal Without Suction Pump: A Surgical Technique. Retina 2011;31:1961-2. [Medline]

117. Aghai GH, Fereidounian NA, Khalatbari M, Hejazian E, Falavarjani KG. Orbitofrontal cholesterol granuloma; Report of two cases and review of literature. Iranian J Ophthalmol 2011;23:60-64. [Scopus]

118. Falavarjani KG, Modarres M. Transscleral Diffusion of Triamcinolone.

Ophthalmology 2011;7:1487. [Medline]

119. Falavarjani KG, Modarres M. Erythropoietin; a Novel Neuroprotective Agent for Ocular Disorders. J Ophthalmic Vis Res 2011;6:76-7. [Pubmed]

120. Modarres M, Falavarjani KG, Nazari H, et al. Intravitreal erythropoietin injection for the treatment of non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol 2011;95:992-995. [Medline]

121. Falavarjani KG, Mohammadreza H, Hejazi SM, Naseripour M. A Modified Semiautomatic Method for Measurement of Hyperfluorescence Area in Fluorescein Angiography. Iranian J Ophthalmol 2010;22(4):73-79. [Scopus]

122. Falavarjani KG. CONSULTATION SECTION. J Cataract Refract Surg

2010;36:1443. [Medline]

123. Foroutan A, Beigzadeh F, Bakhtiari P, Joshaghani M, Falavarjani KG, Afshar AE, Foroutan P. Perilimbal Bevacizumab Injection for Interface Neovascularization After Deep Anterior Lamellar Keratoplasty. Cornea 2010;29:1268-1272. [Medline]

124. Nazari H, Parvaresh MM, Modarres M, Falavarjani KG. Intravitreal

bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage. Graefes Arch Clin Exp Ophthalmol 2010; 248:1713-1718. [Medline]

125. Falavarjani KG, Naseripour M. New Hope for Retinoblastoma Patients. J

Ophthalmic Vis Res 2010;5:213-14. [Pubmed] 126. Falavarjani KG, Modarres M. Perioperative Use of Bevacizumab in Vitrectomy

for Proliferative Diabetic Retinopathy: A Literature review. Iranian J Ophthalmol 2010;22(4):5-12. [Scopus]

127. Nilforushan N, Yadgari M, Falavarjani KG, Afshar AE. Evaluation of Subconjunctival Oculusgen Implantation as an Adjunct to Trabeculectomy. Iranian J Ophthalmol 2010;22(4):55-62. [Scopus]

128. Falavarjani KG, Modarres M, Nazari H. Therapeutic Effect of Bevacizumab

Injected Into the Silicone Oil in Eyes with Neovascular Glaucoma after Vitrectomy for Advanced Diabetic Retinopathy. Eye 2010; 24, 717-719. [Medline]

129. Falavarjani KG, Hashemi M, Modarres M, Sanjari MS, Darvish N, Gordiz A.

Topography-guided vs Wavefront-optimized Surface Ablation for Myopia Using the WaveLight Platoform: A Contralateral Eye Study. Refractive surgery 2011;27(1):13-17. [Medline]

130. Falavarjani KG, Hashemi M, Joshaghani M, Azadi P, Ghaempanah MJ, Aghai GH. Determining corneal power using Pentacam after myopic photorefractive keratectomy. Clinical and Experimental Ophthalmology 2010; 38: 341-345. [Medline]

131. Kashkouli MB, Pakdel F, Amani A, Asefi M, Aghai GH, Falavarjani KG. A

Modified Schirmer Test in Dry Eye and Normal Subjects: Open Versus Closed Eye and 1-Minute Versus 5-Minute Tests. Cornea 2010;29:384-387. [Medline]

132. Falavarjani KG, Modarres M, Nikeghbali A. OCT and cataract. Ophthalmology

2010;117(4):849. [Medline]

133. Naseripour M, Falavarjani KG, Akbarzadeh S. Retinocytoma associated with bilateral retinoblastoma. Indian J Ophthalmol. 2010;58:155-156. [Medline]

134. Falavarjani KG. A Highly Specific Biomarker for Early Diagnosis and

Treatment of Neovascular Age-Related Macular Degeneration. J Ophthalmic Vis Res 2010; 5:71. [Pubmed]

135. Nikeghbali A, Falavarjani KG. Scleral Fixation of Dislocated Intraocular Lenses

by Haptic Externalization through a Clear Corneal Incision. J Ophthalmic Vis Res 2009; 4 (4): 266-269. [Pubmed]

136. Falavarjani KG, Modarres M, Joshaghani M, Azadi P, Hodjat P, Afshar AE.

Interocular differences of the Pentacam measurements in normal subjects. Clinical exp optom 2010; 93: 1: 26-30. [Medline]

137. Parvaresh MM, Modarres M, Falavarjani KG, Sadeghi K, Hammami P.

Transscleral diode laser retinal photocoagulation for the treatment of threshold retinopathy of prematurity. JAAPOS 2009;13(6):535-538. [Medline]

138. Falavarjani KG, Sanjari MS, Modarres M, Aghamohammadi F. Axial length and

refractive error in NAION. Journal of optometry 2009;80:639-641. [Pubmed]

139. Falavarjani KG, Sanjari MS, Modarres M, Aghamohammadi F. Clinical profile

of patients with nonarteritic anterior ischemic optic neuropathy in an Iranian neuro-ophthalmology referral center from 2003 to 2008. Arch of Iranian Medicine 2009; 12(5):472 - 477. [Medline]

140. Naseripour M, Falavarjani KG, Bakhtiari P, Vosough P, Aryan F. Retinoblastom survival in Iran: 10 years experience of a referral center. Iranian J Ophthalmol 2009;21(4):17-24[Scopus] 141. Naseripour M, Falavarjani KG, Oladi MR, Modarres M. Testing Toxicity of

Intravitreal Bevacizumab (Avastin) used for the Treatment of Choroidal

Neovascularization Associated with Age-Related Macular Degeneration: A Full Field ERG Study. Iranian J Ophthalmol 2009;21(3):49-55. [Scopus]

142. Falavarjani KG, Modarres M, Nazari H, Naseripour M, Parvaresh MM. Diabetic

Macular Edema Following Panretinal Photocoagulation. Arch Ophthalmol 2010;128:262. [Medline]

143. Falavarjani KG. Implantable Posterior Segment Drug Delivery Devices; Novel Alternatives to Currently Available Treatments. JOVR 2009; 3: 192-4. [Pubmed]

144. Falavarjani KG, Modarres M. Intravenous Tissue Plasminogen Activator in

Central Retinal Artery Occlusion. Am J Ophthalmol 2009;147:1105. [Medline] 145. Modarres M, Nazari H, Falavarjani KG, Naseripour M, Parvaresh MM, Hashemi

M. Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy. Eur J Ophthalmol 2009; 19: 848-52. [Medline]

146. Falavarjani KG. Gene Therapy for Inherited Retinal Disorders. JOVR 2009;

2:66-7. [Pubmed]

147. Falavarjani KG, Modarres M. Bevacizumab Tachyphylaxis. Ophthalmology 2009;116:1016-1017. [Medline]

148. Kashkouli, MB, Aghai GH, Falavarjani KG, Astaraki A, Mirzajani H,

AghaMohammadi F. Modified Schirmer's Test in Normal Eyes: Open versus Closed Eyes and 1-minute versus 5-minute Tests. Iranian J Ophthalmol 2009;21(1):52-56. [Scopus]

149. Modarres M, Naseripour M, Falavarjani KG. Intravitreal Injection of 2.5 mg VS

1.25 mg Bevacizumab (Avastin) for Treatment of CNV Associated with AMD. Retina 2009;29:319-324. [Medline]

150. Sanjari MS, Falavarjani KG, Mehrabani M, Ghiasian L, Zamani B. Retrobulbar

hemodynamics and carotid wall thickness in patients with nonarteritic anterior ischemic optic neuropathy. Br J Ophthalmol 2009;93;638-640. [Medline]

151. Sanjari MS, Falavarjani KG, Kashkouli MB, Aghai GH, Nojomi M, Rostami H.

Botulinum toxin-A injection with and without electromyographic assistance for treatment of sixth cranial nerve palsy: a pilot study. J AAPOS 2008;12(3):259-62. [Medline]

152. Nikeghbali A, Falavarjani KG. Modified transscleral fixation technique for

refixation of dislocated intraocular lenses. J Cataract Refract Surg 2008; 34:743-748. [Medline]

153. Asadi R, Falavarjani KG. Anterior and nasal transposition of the inferior oblique muscle in patients with inferior oblique muscle overaction. Iranian J Ophthalmol 2008;20(2):41-45. [Scopus]

154. Kashkouli, MB, Khalatbari MR, Falavarjani KG, Ghaleanovi H, Sanjari MS,

Zaman B. Subarachnoid Hemorrhage Following Uneventful Thyroid Orbital Decompression. Ophthalm Plastic Recons Surg 2007;23:316-8. [Medline]

155. Nilforushan N, Falavarjani KG, Razeghinejad MR, Bakhtiari P. Cataract Surgery

for Congenital Cataract: Endothelial Cell Characteristics, Corneal Thickness and Impact on Intraocular Pressure. J AAPOS 2007;11:159-161. [Medline]

156. Modarres M, Sanjari MS, Falavarjani KG. Vitrectomy and Release of Presumed

Epipapillary Vitreous Traction for Treatment of Nonarteritic Anterior Ischemic Optic Neuropathy Associated with Partial Posterior Vitreous Detachment. Ophthalmology 2007;114:340-344. [Medline]

157. Nikeghbali A, Falavarjani KG, Kheirkhah A, Bakhtiari P, Kashkouli MB. Pupil

Dilation with Intracameral Lidocaine during Phacoemulsification. J Cataract Refract Surg 2007; 33:101-103. [Medline]

158. Asadi R, Falavarjani KG. Anteriorization of Inferior Oblique Muscle and

Downward Transposition of Medial Rectus Muscle for Lost Inferior Rectus Muscle. J AAPOS 2006;10:592-593. [Medline]

159. Sanjari MS, Falavarjani KG, Kashkouli MB. Bilateral Peripapillary Staphyloma,

A Clinicoradiologic Report. Br J Ophthalmol 2006;90;1326-1327. [Medline]

160. Sanjari MS, Falavarjani KG, Parvaresh MM, Kharazi HH and Kashkouli MB. Bilateral aplasia of the optic nerve, chiasm, and tracts in an otherwise healthy infant. Br J Ophthalmol 2006;90;513-514. [Medline]

161. Soltan Sanjari M, Falavarjani KG, Parvaresh MM, Modarreszadeh M,

Naseripour M, Hashemi M, Nojomi M. Vitreopapillary traction in non-arteritic anterior ischemic optic neuropathy. Iranian J Ophthalmic Res. 2006.1(2).110-112. [Pubmed]

162. Nikeghbali A, Falavarjani KG, Kheirkhah A. Pupil Dilation with Intracameral

Lidocaine During Phacoemulsification; Benefits for the Patient and Surgeon. Indian Journal of Ophthalmology 2008;56:63-4. [Medline]

163. Asadi R, Falavarjani KG. Results of amblyopia therapy in unilateral organic

ocular abnormalities. Iranian J Ophthalmol 2008;20(3):24-27. [Scopus]

164. Asadi R, Falavarjani KG, Sadighi N. Orthoptic Treatment in the Management of Intermittent Exotropia. Iranian J Ophthalmol 2009;21(1):35-40. [Scopus]

165. Kashkouli, MB, Parvaresh MM, Mirzajani H, Astaraki A, Falavarjani KG,

Ahadian A. Intraoperative Mitomycin C Use During Filtration Surgery and Lacrimal Drainage System Obstruction. Am J Ophthalmol 2009;147:453-457. [Medline]

166. Sanjari MS, Parvaresh MM, Maleki A, Falavarjani KG, Pejman Bakhtiari.

Correlation between Retinal Nerve Fiber Layer Thickness by Optical Coherence Tomography and Perimetric Parameters in Optic Atrophy. J Ophthalmic Vis Res 2008;3:91-94. [Pubmed]

167. Falavarjani KG, Hashemi M, Modarres M, Nilforushan N. Corneal power

measurements with Pentacam after keratorefractive surgery. J Cataract Refract Surg 2009;35:612. [Medline]

168. Falavarjani KG, Modarres M, Foroutan AR, Bakhtiari P. Fibrin glue-assisted

sutureless scleral fixation. J Cataract Refract Surg 2009;35:795. [Medline]

169. Parvaresh MM, Ghiasian L, Falavarjani KG, Soltan-Sanjari M, Sadighi N. Normal Values of Standard Full Field Electroretinography in an Iranian Population. J Ophthalmic Vis Res 2009; 4 (2): 97-101. [Pubmed]

B. Farsi publications:

1. Amjadi A, Falavarjani KG, Moazami N. Simultaneous measurement of refractive index and physical thickness of multiple layers using the results of Fourier domain optical coherence tomography. Iranian Journal of Physics Research. 2018;18: 115-124.

2. Hashemi M, Falavarjani KG, et al. Challenges in vitreoretinal surgery. Farsi book. 2011. Tehran, Iran.

3. Joshaghani M, Forootan A, Ghasemi H, Falavarjani KG, Madarshahi H, Nikbakht B. Evaluation of the efficacy of scar revision at graft-recipient junction for reduction of astigmatism incidence following penetrating keratoplasty. Daneshvar, 2010;17:1-7.

4. Falavarjani KG. Glaucoma diagnosis and screening. Family physicians empowerment training program (digital release). 2011. VHDI Inc.

5. Nilforushan N, Parvaresh MM, Amidirad D, Modarres-Zadeh M, Hashemi M, Falavarjani KG, Ahadian A. Trans-Scleral Diode Laser Cyclophotocoagulation for Management of Elevated Intraocular Pressure after Pars-Plana Vitrectomy. Bina J Ophthalmol 2010; 15: 289-297 . [www.sid.ir]

6. Modarres M, Nazari, Kanavi MR, Falavarjani KG, Ghasempour A. Evaluation of the safe doses of bevacizumab in rabbit eyes. Bina J Ophthalmol 2010; 15: 186-192. [www.sid.ir]

7. Falavarjani KG, Parvaresh MM, Sanjari MS, Modarres M, Aghamohammadi F, Ghasempour A. Evaluation of sclera canal diameters using OCT in patients with NAION. Laser in medicine 2009;3:19-22. [www.sid.ir]

8. Falavarjani KG, Hashemi M. How to encounter the computer related ocular problems. Farsi book. 2009. Tehran, Iran.

9. Falavarjani KG, Modarres, Hodjat P, Afshar AE, Ghasempour A. Laser in diabetic retinopathy. Laser in medicine 2009;1:36-44. [www.sid.ir]

10. Falavarjani KG, Hashemi M, Parvaresh MM, Modarres M, Sanjari MS, Afshar AE. Study of the knowledge and attitude of computer users about the computer related eye problems. Bina J Ophthalmol 2010; 15 (2): 121-127. [www.sid.ir]

11. Falavarjani KG, Sanjari MS, Modarres M, Mehrabani M, Rohani M,

Aghamohammadi F. Ophthalmic artery flow velocity in patients with acute unilateral nonarteritic anterior ischemic optic neuropathy. Bina J Ophthalmol 2009;15:3-7. [www.sid.ir]

12. Mohammadreza H, Hejazi SM, Oghabian MA, Ahmadian AR, Naseripour M,

Zarrin M, Falavarjani KG, Nazari H. Measurement of the area of CNV secondary to AMD using a modified threshold method. Iranian Journal of Biophysics. 2008; 5:77-84.

13. Hashemi M, Falavarjani KG. Vitrectomy for Complications of Branch Retinal Vein

Occlusion. Bina J Ophthalmol 2009; 14 (4): 378-383. [www.sid.ir] 14. Falavarjani KG, Mehrabani M, Ghiasian L, Sanjari MS, Zamani B, Oladi MR,

Modarres M. Carotid wall thickness in patients with acute unilateral nonarteritic anterior ischemic optic neuropathy. Bina J Ophthalmol; 14:121-124. [www.sid.ir]

15. Naseripour M, Falavarjani KG, Mirfallah K, Bagheri R. Photodynamic therapy for

vasoproliferative tumors and capillary hemangiomas of the retina. Bina J Ophthalmol 2009;14:109-115. [www.sid.ir]

16. Parvaresh MM, Falavarjani KG. Butterfly-Shaped Macular Dystrophy. Bina J

Ophthalmol 2006;12(1):101-104. [www.sid.ir]

17. Sanjari MS, Shokrollahi S, Falavarjani KG. Refractive and corneal topographic changes after hang-back strabismus surgery. Medical journal of Iran university of medical sciences 2010;68:49-55.

18. Nikeghbali A, Falavarjani KG, Modarreszadeh M, Hashemi M, Parvaresh MM, Naseripour M. longterm results of scleral fixation. Medical journal of Iran university of medical sciences 2009:63:169-175.

19. Hashemi M, Akbarzadeh S, Falavarjani KG. Outcomes of heavy silicon oil tamponade in

complicated retinal detachment surgery. Bina J Ophthalmol 2008;13:418-423.

20. Modarres M, Falavarjani KG, Salehian M, Seddigh N, Sanjari MS. Evaluation of the prevalence of systemic disease in patients with anterior ischemic optic neuropathy in Rassoul Akram hospital. Medical journal of Iran university of medical sciences 2009;63:126-132.

21. Hashemi M, Falavarjani KG, Navahi RA, Mirfallah K, Bakhtiari P. Comparison of the

results of intravitreal injection of triamcinolone acetonide and bevacizumab (Avastin) in patients with clinically significant macular edema unresponsive to standard treatment. Medical journal of Iran university of medical sciences 2009;63:201-208.

22. Falavarjani KG, Hashemi M. Principles of modern laser refractive surgery. Markazi eye

clinic, Tehran. 2007. (Farsi book) 23. Falavarjani KG, Bayanati sh, Vaghari B. Rheumatologic and immune system diseases.

In: Harrison`s Principles of Internal Medicine. 16th ed. Samat, Tehran. 2005. (Farsi translation). [www.nlai.ir]

24. Falavarjani KG, Maylie B. Weekly epidemiological record 1997. World Health

Organization magazine. (Digital network database, Farsi translation as final thesis)

PRESENTATIONS AT SCIENTIFIC MEETINGS

1. Macular nonperfusion after anti-VEGF in CME. 7th OCT and OCTA Meeting. Dec 2019. Rome, Italy. (Lecture)

2. Effect of segmentation error correction in DME. 7th OCT and OCTA Meeting. Dec 2019. Rome, Italy. (Lecture)

3. Role of OCTA in diabetic eye diseases. 29th Iranian Congress of Ophthalmology. Mashhad, Iran. Nov 2019. (Lecture)

4. Update on retinal imaging. 29th Iranian Congress of Ophthalmology. Mashhad,

Iran. Nov 2019. (Moderator)

5. The effect of intravitreal TPA on diabetic tractional fibrovascular membranes; proposed criteria using OCT. 29th Iranian Congress of Ophthalmology. Mashhad, Iran. Nov 2019. (Oral presentation)

6. Film Presentation. Euretina. Paris, France. September 2019.

7. Controversies in Management of Macular Edema Refractory to Anti VEGF Agents. 3rd Spring Ophthalmology meeting. Tehran, Iran. April 2019. (Moderator)

8. Macular vessel density changes after anti-VEGF in CME. 6th OCT and OCTA Meeting. Dec 2018. Rome, Italy. (Lecture)

9. What is new in retinal imaging? 28th Iranian Congress of Ophthalmology. Tehran, Iran. Nov 2018. (Lecture)

10. Vitrectomy in refractory DME (Cons). 28th Iranian Congress of Ophthalmology. Tehran, Iran. Nov 2018. (Lecture)

11. Update on retinal imaging. 28th Iranian Congress of Ophthalmology. Tehran, Iran. Nov 2018. (Moderator)

12. Controversies on RVO. 2nd Spring Ophthalmology meeting. Tehran, Iran. April 2018. (Moderator)

13. OCTA Applications. 2nd Spring Ophthalmology meeting. Tehran, Iran. April 2018. (Lecture)

14. Diabetic retinopathy. Diabetes Preceptorship Program. Institute of Endocrinology and Metabolism. Tehran, Iran. April 2018. (Lecture)

15. Retina Subspecialty Day: The Role of Choroid in Fundus Disorders. 27th Iranian

congress of ophthalmology. Tehran, Iran. Dec 2017. (Moderator)

16. Role of OCT in Diagnosis and Management of Vitreoretinal Disease in Pediatric Age Group. 27th Iranian congress of ophthalmology. Tehran, Iran. Dec 2017. (Lecture)

17. Interpretation of OCTA Images. 27th Iranian congress of ophthalmology. Tehran, Iran. Dec 2017. (Lecture)

18. Clinical Applications of OCT Angiography. 27th Iranian congress of ophthalmology. Tehran, Iran. Dec 2017. (Lecture)

19. Interface Vitrectomy For Redetachment Associated With Proliferative

Vitreoretinopathy. 27th Iranian congress of ophthalmology. Tehran, Iran. Dec 2017. (Video presentation)

20. Foveal Avascular Zone Area and Vessel Density Correlate With Foveal Thickness in Healthy Subjects. 27th Iranian congress of ophthalmology. Tehran, Iran. Dec 2017. (free paper)

21. Correlation of Optic Disc Morphometry and Disc Microvasculature Assessed With Optical Coherence Tomography Angiography. 27th Iranian congress of ophthalmology. Tehran, Iran. Dec 2017. (free paper)

22. Optical Coherence Tomography Angiography Features of Optic Nerve Head Drusen and Nonarteritic Anterior Ischemic Optic Neuropathy. 27th Iranian congress of ophthalmology. Tehran, Iran. Dec 2017. (free paper)

23. OCT angiography in AMD. 51th Turkish congress of ophthalmology. Antalya, Turkey. Dec 2017. (Lecture)

24. Distribution of Nonperfusion Area on Ultra Widefield Angiography in Eyes with Diabetic Macular Edema: DAVE Study. ARVO. Baltimore, US. May 2017. (Poster)

25. En Face OCT Analysis to Assess the Spectrum of Perivenular Ischemia and PAMM in Retinal Vascular Occlusion. ARVO. Baltimore, US. May 2017. (Poster).

26. Multicolor SLO image analysis of patients with LHON. ARVO. Baltimore, US. May 2017. (Poster)

27. Optical coherence tomography angiography analysis of the foveal avascular zone and macular vessel density after anti-VEGF therapy in eyes with diabetic macular edema and retinal vein occlusion. ARVO. Baltimore, US. May 2017. (Poster)

28. Swept source OCT angiography of the optic disc in optic neuropathy. AAO Annual Meeting. Chicago, US. Oct 2016. (Poster)

29. Role of OCTA in Diagnosis and Follow Up of AMD Patients. 26th Iranian congress of ophthalmology. Tehran, Iran. Dec 2016. (Lecture)

30. OCT Angiography: Indications and Limitations. 26th Iranian congress of ophth

almology. Tehran, Iran. Dec 2016. (Lecture)

31. OCT Interpretation. 26th Iranian congress of ophthalmology. Tehran, Iran. Dec 2016. (Moderator)

32. Abnormal Vessels in the Foveal Center in Premature Eyes: An Optical Coherence

Tomography Angiography StudyRetina Society Meeting. Sep 2016. San Diego, USA. (Free paper)

33. Update on postop CME. Farabi Annual Meeting. May 2015. Tehran, Iran. (Lecture)

34. Management of complications after intravitreal injections. Farabi Annual Meeting. May 2015. Tehran, Iran. (Lecture)

35. Management of diabetic retinopathy. Annual Meeting of the Iranian Vitreoretinal Society and Isfahan Eye Department Annual Meeting. April 2015. Isfahan, Iran. (Panel member)

36. OCT Artifacts and The Graphs in OCT Reports That We Do Not Care Them. 24th Iranian congress of ophthalmology. Tehran, Iran. Dec 2014. (Lecture)

37. Scleral Buckling Surgery for Rhegmatogenous Retinal Detachment with Subretinal Proliferation. 24th Iranian congress of ophthalmology. Tehran, Iran. Dec 2014. (Free paper)

38. Effect of Grid Decentration on Macular Thickness Measurements in Normal Subjects and Patients with Diabetic Macular Edema. 24th Iranian congress of ophthalmology. Tehran, Iran. Dec 2014. (Free paper)

39. Electronic Patients Recording and Tele-ophthalmology: Future of Ophthalmology. 24th Iranian congress of ophthalmology. Tehran, Iran. Dec 2014. (Moderator)

40. 2014 Young Ophthalmologist Program, Retina Session. 24th Iranian congress of ophthalmology. Tehran, Iran. Dec 2014. (Moderator)

41. Intra-silicone oil injection of methotrexate at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy. Euretina. London, UK. Sep 2014. (Free paper)

42. Intra-silicone Oil Injection Of Methotrexate At The End Of Vitrectomy For

Retinal Detachment Associated With Severe Proliferative Diabetic Retinopathy. Euretina. London, UK. Sep 2014. (Free paper)

43. Controversies in the management of vitreomacular interface disorders. IUMS Eye Research Center Annual Meeting. Tehran, Iran. July 2014. (Moderator)

44. Update on CSCR. Annual Meeting of the Iranian Vitreoretinal Society and Tabriz Eye Department Annual Meeting. June 2014. Tabriz, Iran. (Lecture)

45. Management of Anti-VEGF non-responders. Farabi Annual Meeting. April 2014. Tehran, Iran. (Lecture)

46. Color Photography and Fluorescein Angiography. World Ophthalmology Congress (WOC), Tokyo, Japan, April 2014. (Lecture)

47. The 4th annual congress of Iranian research association for vision and ophthalmology (IRAVO). Feb 2014. Razi Convention Center, Tehran, Iran. (Chair)

48. Peripapillary Nerve Fiber Layer Thickness Changes after Macular Photocoagulation for Clinically Significant Diabetic Macular Edema. The 4th annual congress of IRAVO. Feb 2014. Razi Convention Center, Tehran, Iran. (Free paper)

49. Diagnosis and treatment of CSCR. Shahid Beheshti annual ophthalmology seminar. Jan 2014. Razi Convention Center, Tehran, Iran.

50. Treatment of dry AMD, an update. One day symposium. Farabi Eye Hospital. Jan 2014. Tehran, Iran. (Lecture)

51. Approach to Common Macular Disorders (Symposium). 23rd Iranian congress of ophthalmology. Tehran, Iran. Oct 2013. (Moderator)

52. Approach to CSCR. 23rd Iranian congress of ophthalmology. Tehran, Iran. Oct

2013. (Lecture)

53. Ultrasonography in Vitreoretinal Diseases (Workshop). 23rd Iranian congress of ophthalmology. Tehran, Iran. Oct 2013. (Moderator)

54. Basic Ultrasonography Examination Techniques. 23rd Iranian congress of ophthalmology. Tehran, Iran. Oct 2013. (Lecture)

55. Case Presentation and OCT Interpretation. 23rd Iranian congress of ophthalmol

ogy. Tehran, Iran. Oct 2013. (Panel Discussion)

56. Peripapillary Nerve Fiber Layer Thickness Changes after Macular Photocoagulation for Clinically Significant Diabetic Macular Edema. 23rd Iranian congress of ophthalmology. Tehran, Iran. Oct 2013. (Free paper)

57. Optical Coherence Tomography Grid Decentration after Manual Overlay Adjustment and Its Effect on Macular Thickness Measurements. 23rd Iranian congress of ophthalmology. Tehran, Iran. Oct 2013. (Free paper)

58. Dry Eye after Microincision and Conventional Vitrectomy. 23rd Iranian congress of ophthalmology. Tehran, Iran. Oct 2013. (Free paper)

59. Intra-silicone oil injection of bevacizumab at the end of retinal reattachment surge

ry for severe proliferative vitreoretinopathy. 23rd Iranian congress of ophthalmology. Tehran, Iran. Oct 2013. (Free paper)

60. Intra-silicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy. Euretina. Hamburg, Germany. Sep 2013. (Free paper)

61. Controversies in the cataract surgery in macular disorders. IUMS Eye Research Center Annual Meeting. Tehran, Iran. July 2013. (Moderator)

62. Approach to CSR. Annual Meeting of the Iranian Vitreoretinal Society and Farabi Annual Meeting. Tehran, Iran. Apr. 2013. (Lecture)

63. How to retrieve educational materials on AAO website. 22th Iranian congress of ophthalmology. Tehran, Iran. Nov 2012. (Lecture)

64. Ranibizumab for Edema of the mAcula in Diabetes (READ -2 study). 22th

Iranian congress of ophthalmology. Tehran, Iran. Nov 2012. (Lecture)

65. General ocular and systemic complications of intraocular injection of anti-VEGF agents. 22th Iranian congress of ophthalmology. Tehran, Iran. Nov 2012. (Lecture)

66. Incidence of acute endophthalmitis after intravitrealbevacizumab injection in a single clinical center. 22th Iranian congress of ophthalmology. Tehran, Iran. Nov 2012. (Presentation)

67. FA, ICG, and OCT Case Presentations. 22th Iranian congress of ophthalmology. Tehran, Iran. Nov 2012. (Lecture)

68. Anti VEGF Therapy Vs Combined PDT and Anti VEGF Therapy for Neovascular Age-Related Macular Degeneration. WOC. Abudhabi, UAE. Feb 2012. (Lecture)

69. Parsplana vitrectomy and Intravitreal phacoemulsification for removal of the dropped nucleus. WOC. Abudhabi, UAE. Feb 2012. (Free paper)

70. Vitrectomy for posterior segment intraocular foreign bodies; visual and anatomical outcomes. WOC. Abudhabi, UAE. Feb 2012. (Free paper)

71. Interactive session on uveitis. WOC. Abudhabi, UAE. Feb 2012. (Lecture)

72. ROP treatment and follow up. One day Pediatric Retina seminar. Labbafinejad Medical Center. Tehran, Iran. Dec 2011. (Lecture)

73. Basic techniques for B scan ultrasonography. 21th Iranian congress of

ophthalmology. Tehran, Iran. Nov 2011. (Lecture)

74. Ultrasonography for fundus mass. 21th Iranian congress of ophthalmology. Tehran, Iran. Nov 2011. (Lecture)

75. Surgical treatment for submacular hemorrhage. 21th Iranian congress of ophthalmology. Tehran, Iran. Nov 2011. (Lecture)

76. Guide line for retinal break. 21th Iranian congress of ophthalmology. Tehran, Iran. Nov 2011. (Lecture)

77. Intravitreal injection of bevacizumab for severe ROP. 21th Iranian congress of ophthalmology. Tehran, Iran. Nov 2011. (Free paper)

78. Determination of the exact crossing point of the corneal thickness spatial profile line and the normal progression line in keratoconus and normal eyes using specially designed software. ESCRS. Vienna, Austria. Sep 2011(Free paper)

79. Longterm complications following Ru-106 plaque radiotherapy for uveal melanoma.

20th Iranian congress of ophthalmology. Tehran, Iran. Nov 2010. (Free paper) 80. Evaluation of scleral canal diameters at optic nerve head using OCT in patients with

NAION. 20th Iranian congress of ophthalmology. Tehran, Iran. Nov 2010. (Free paper)

81. Biphasic pattern of response to intravitreal erythropoietin injection for treatment of

nonarteritic anterior ischemic optic neuropathy (NAION). 20th Iranian congress of ophthalmology. Tehran, Iran. Nov 2010. (Free paper)

82. Intraoperative use of mitomycin C during vitrectomy for prevention of PVR recurrence in post vitrectomy eyes with RRD complicated by severe PVR. 20th Iranian congress of ophthalmology. Tehran, Iran. Nov 2010. (Free paper)

83. What does clinical trials tell us about treatment of BRVO? 20th Iranian congress of

ophthalmology. Tehran, Iran. Nov 2010. (Lecture)

84. Ultrasonographic screening of the fundus. 20th Iranian congress of ophthalmology. Tehran, Iran. Nov 2010. (Lecture)

85. Ultrasonographic evaluation of the fundus mass. 20th Iranian congress of ophthalmology. Tehran, Iran. Nov 2010. (Lecture)

86. Basics of IOL calculation. 13th Iranian congress of optometry. Tehran, Iran,

September 2010. (Lecture)

87. Nutritional supplements for preventing AMD. 4th seminar of IUMS eye department, Tehran, Iran, August 2010. (Lecture)

88. Neuroprotection in optic neuropathies. 3rd congress of vitreoretinal society, Shiraz, Iran, June 2010. (Lecture)

89. Full field ERG deficits in wet AMD. 19th Iranian congress of ophthalmology. Tehran, Iran. Nov 2009. (Free paper)

90. Erythropoietin for the treatment of NAION. 19th Iranian congress of ophthalmology. Tehran, Iran. Nov 2009. (Free paper)

91. Brachytherapy for uveal malignant melanoma in terms of visual function. 19th Iranian

congress of ophthalmology. Tehran, Iran. Nov 2009. (Free paper)

92. Sandwitch therapy for the treatment of uveal malignant melanoma. 19th Iranian congress of ophthalmology. Tehran, Iran. Nov 2009. (Free paper)

93. A modified shirmer test in normal subjects and dry eye: open versus closed eyes and i-minute versus 5-minute test. 19th Iranian congress of ophthalmology. Tehran, Iran. Nov 2009. (Free paper)

94. Transscleral diod laser photocoagulation for the treatment of type one ROP. 19th Iranian congress of ophthalmology. Tehran, Iran. Nov 2009. (Free paper)

95. Ocular Emergencies. 12th Iranian congress of optometry. Tehran, Iran, August 2009. (Lecture)

96. Pentacam workshop. Pentacam one day workshop. Rassoul Akram Hospital,

Tehran, Iran, July 2009. (Moderator)

97. Pentacam maps. Pentacam one day workshop. Rassoul Akram Hospital, Tehran, Iran, July 2009. (Lecture)

98. Ocular side effects of systemic drugs. Pharmacotherapy in ophthalmology. Three-day

symposium. Tehran, Iran, Apr 2009. (Lecture) 99. Corticosteroids in uveitis. Pharmacotherapy in ophthalmology. Three-day symposium.

Tehran, Iran, Apr 2009. (Lecture) 100. Pentacam keypoints. Medical college, Iran university of medical sciences. One-

day optometry symposium. Tehran, Iran, Nov 2008. (Lecture) 101. OCT; 40 pictures, 40 explanations. Medical college, Iran university of medical

sciences. One-day optometry symposium. Tehran, Iran, Nov 2008. (Lecture) 102. Biometry accuracy. Medical college, Iran university of medical sciences. One-

day optometry symposium. Tehran, Iran, Nov 2008. (Lecture) 103. Ophthalmic Nursing workshop. 18th Iranian congress of ophthalmology.

Tehran, Iran. Nov 2008. (Moderator 104. Therapeutic Effect of Bevacizumab Injected Into the Silicon Oil in Eyes With

Rubeotic Glaucoma After Vitrectomy for Proliferative Diabetic Retinopathy. 18th Iranian congress of ophthalmology. Tehran, Iran. Nov 2008. (Free paper)

105. Ruthenium brachytherapy for retinoblastoma. 18th Iranian congress of

ophthalmology. Tehran, Iran. Nov 2008. (Free paper) 106. Primary Transpupillary Thermotherapy for Small Choridal Melanoma. 18th

Iranian congress of ophthalmology. Tehran, Iran. Nov 2008. (Free paper) 107. Combined phacoemulsification, intraocular lens implantation and parsplana

vitrectomy in advanced diabetic retinopathy. 18th Iranian congress of ophthalmology. Tehran, Iran. Nov 2008. (Free paper)

108. Transscleral diode laser photocoagulation in the treatment of threshold

retinopathy of prematurity. 18th Iranian congress of ophthalmology. Tehran, Iran. Nov 2008. (Free paper)

109. Standardized full field electroretinography: normal values and variation with

age. 18th Iranian congress of ophthalmology. Tehran, Iran. Nov 2008. (Free paper) 110. Intravitreal use of bevacizumab (Avastin) for choroidal neovascularization

associated with age related macular degeneration: a full field ERG study. 18th Iranian congress of ophthalmology. Tehran, Iran. Nov 2008. (Free paper)

111. Photodynamic therapy in retinal angiomatosis proliferations. 18th Iranian

congress of ophthalmology. Tehran, Iran. Nov 2008. (Free paper) 112. Review of congenital disinnervation syndromes. 18th Iranian congress of

ophthalmology. Tehran, Iran. Nov 2008. (Free paper) 113. Effects of homatropine on pain control and relief in patients undergoing

photorefractive keratectomy surgery. 18th Iranian congress of ophthalmology. Tehran, Iran. Nov 2008. (Free paper)

114. Therapeutic Effect of Bevacizumab Injected Into the Silicon Oil in Eyes With

Rubeotic Glaucoma After Vitrectomy for Proliferative Diabetic Retinopathy. Annual Meeting of the American Academy of Ophthalmology. New Orleans, USA. Nov 2008. (Poster presentation)

115. Clinical anatomy of the eye. Two-day symposium for general physicians.

Tehran, Iran, October 2008. (Lecture) 116. The eye in hypertension. 11th Iranian congress of optometry. Tehran, Iran,

August 2008. (Lecture) 117. Pentacam. Rassoul Akram Hospital, One-day symposium. Tehran, Iran, July

2008. (Lecture) 118. Orbscan. Rassoul Akram Hospital, One-day symposium. Tehran, Iran, July

2008. (Lecture) 119. Orbscan VS Pentacam. Rassoul Akram Hospital, One-day symposium. Tehran,

Iran, January 2008. (Lecture) 120. Custom ablation. Rassoul Akram Hospital, One-day symposium. Tehran, Iran,

January 2008. (Lecture) 121. Study design. Rassoul Akram Hospital, One-day symposium. Tehran, Iran,

January 2008. (Lecture) 122. Refixation of Dislocated Intraocular Lens: A Modified Surgical Technique. 17th

Iranian congress of ophthalmology. Tehran, Iran. Dec 2007. (Free paper) 123. Intravitreal Injection of 2.5mg vs. 1.25mg Bevacizumab for Treatment of CNV

Associated With AMD. Annual Meeting of the American Academy of Ophthalmology. New Orleans, USA. Nov 2007. (Poster presentation)

124. Vitreopapillary Traction in Nonarteritic Anterior Ischemic Optic Neuropathy

(NAION). Middle East African council of ophthalmology. UAE, Dubai. April-March 2007. (Free paper)

125. Intravitreal Injection of Bevacizumab for Treatment of Macular Edema after

Retinal Vein Occlusion. Middle East African council of ophthalmology. UAE, Dubai. April-March 2007. (Free paper)

126. Complications associated with Intravitreal injection of Bevacizumab. Middle

East African council of ophthalmology. UAE, Dubai. April-March 2007. (Free paper) 127. OCT findings in Vitreoretinal Interface Abnormalities. OCT News course,

Central Eye Clinic, Tehran, Iran. Jan 2007. (Oral lecture) 128. Release of vitreopapillary traction as a management of non arteritic anterior

ischemic optic neuropathy. 14th Iranian congress of ophthalmology, Tehran, Iran. Dec 2004. (Free paper)

129. Vitreopapillary traction as a cause of non-arteritic anterior ischemic optic

neuropathy. 15th Iranian congress of ophthalmology, Tehran, Iran. Dec 2005. (Free paper)

MEMBERSHIP

REFERENCES

130. Indocyanine green angiography. Interactive course of retina and vitreous, Iran University of Medical Sciences. Tehran, Iran. Aug 2006. (Lecture)

131. Intravitreal bevacizumab for the treatment of choroidal neovascularization. 16th

Iranian congress of ophthalmology, Tehran, Iran. Nov 2006. (Free paper) 132. Vitrectomy and release of presumed epipapillary vitreous traction for treatment

of Nonarteritic anterior ischemic optic neuropathy. European neuro-ophthalmology society, 7th meeting, Moscow, Russia. June 2005. (Poster presentation)

133. Vitreopapillary Traction in Non-Arteritic Anterior Ischemic Optic Neuropathy

(NAION). International neuro-ophthalmology society meeting, Tokyo, Japan. Nov 2006. (Poster presentation)

134. Pupil Dilation with Intracameral Lidocaine during Phacoemulsification. Joint

Meeting of the American Academy of Ophthalmology and the Asia Pacific Academy of Ophthalmology (APAO). Las Vegas, Nevada, USA. Nov 2006. (Poster presentation)

1. Iran National Elites Foundation 2. European Society of Retina Specialists (Euretina) 3. Middle East African Council of Ophthalmology (MEACO) 4. Iranian Vitreoretina Society 5. Iranian Society of Ophthalmology (IrSO) 6. Iran Medical Council 7. The Association for Research in Vision and Ophthalmology

1. Mehdi Modaress, MD, Professor in Clinical Ophthalmology and Vitreoretinal

surgery. Iran University of Medical Sciences. Rassoul Akram Hospital, Sattarkhan-Niayesh St., Tehran 14455-364, Iran. Tel and Fax +98 21 66509162 Mmodarress51@yahoo.com 2. Mohsen Bahmani Kashkouli, MD, Professor in Clinical Ophthalmology and

Ophthamic Plastic Surgery. Iran University of Medical Sciences. Rassoul Akram Hospital, Sattarkhan-Niayesh St., Tehran 14455-364, Iran. Tel and Fax +98 21 66509162

bahmanik@yahoo.com 3. Mohammad Mehdi Parvaresh, MD, Professor in Clinical Ophthalmology and

Vitreoretinal surgery. Iran University of Medical Sciences. Rassoul Akram Hospital, Sattarkhan-Niayesh St., Tehran 14455-364, Iran. Tel and Fax +98 21 66509162 mmparvaresh@yahoo.com 4. Masood Naseripour, MD, Professor in Clinical Ophthalmology and Ocular Oncology.

Iran University of Medical Sciences. Rassoul Akram Hospital, Sattarkhan-Niayesh St., Tehran 14455-364, Iran. Tel and Fax +98 21 66509162 masoodnp@yahoo.com